Hugh McMillan
Investigator
Professor, Pediatric Neurology, University of Ottawa
Pediatric Neurologist and Neuromuscular specialist at the Children’s Hospital of Eastern Ontario
NMD4C Involvement: Pillar 2: Clinical Research
Email HughBiography
Dr. McMillan is a Pediatric Neurologist with specialization in Clinical Neurophysiology and Neuromuscular medicine at the Children’s Hospital of Eastern Ontario. He is a Professor in the Department of Pediatrics, Faculty of Medicine at the University of Ottawa. He holds a Clinical Research Chair (Level 2) at the University of Ottawa and is a Clinical Investigator at the CHEO Research Institute
He has been an author of over 125 publications in peer-review journals and was a co-editor of a Pediatric Electromyography textbook. He is also a leader in clinical and translational research in pediatric neurology & neuromuscular medicine.
Dr. McMillan completed a Neuromuscular and Neurophysiology Fellowship at Boston Children’s Hospital, Harvard University and the Lahey Clinic, Tufts University; a Pediatric Neurology Residency at the Children’s Hospital of Eastern Ontario, University of Ottawa and a Pediatric Residency at McMaster Children’s Hospital, McMaster University.
Recent Publications
Gotfrit, R, Wilson, N, Matzinger, M, McMillan, HJ. Internal Carotid Arteritis Associated with Sinusitis in a Child: Potential Benefit of Corticosteroids. Can J Neurol Sci. 2024. 1-3 PMID:39450494
Macpherson, KJ, POSTVenTT International Collaborative . Postoperative anaemia increases unplanned readmission: an international prospective cohort study of patients undergoing major abdominal surgery. Br J Surg. 2024.111 (7) PMID:39431881
Freeman, E, Langlois, S, Leyba, MF, Ammar, T, Léger, Z, McMillan, HJ et al.. Pannexin 1 dysregulation in Duchenne muscular dystrophy and its exacerbation of dystrophic features in mdx mice. Skelet Muscle. 2024.14 (1)8 PMID:38671506
Dang, UJ, Damsker, JM, Guglieri, M, Clemens, PR, Perlman, SJ, Smith, EC et al.. Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy: A Randomized Controlled Trial. Neurology. 2024.102 (5)e208112 PMID:38335499
Muntoni, F, Byrne, BJ, McMillan, HJ, Ryan, MM, Wong, BL, Dukart, J et al.. The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy. Neurol Ther. 2024.13 (1)183-219 PMID:38190001
See more on PubMed